{"id":"W2953592136","doi":"10.1053/j.gastro.2019.06.038","title":"Endoscopic, Radiologic, and Histologic Healing With Vedolizumab in Patients With Active Crohn’s Disease","year":2019,"lang":"en","type":"article","venue":"Gastroenterology","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":211,"is_retracted":false,"has_abstract":false,"ca_institutions":"Robarts Clinical Trials; Western University","funders":"UCB Pharma; Janssen Pharmaceuticals; Ferring Research Institute; Sandoz; Bristol-Myers Squibb Canada; Ipsen; Tillotts Pharma; Ferring Pharmaceuticals; Shire; Novo Nordisk; Celltrion; Merck; United Soybean Board; Janssen Research and Development; UCB; Ironwood Pharmaceuticals, Incorporated; Regeneron Pharmaceuticals; Takeda Pharmaceutical Company; AbbVie; Janssen Biotech; Johnson and Johnson; Meso Scale Diagnostics; Teva Pharmaceutical Industries; Novartis; Celgene; Pfizer; Biogen; Gilead Sciences; Roche; Kyowa Hakko Kirin; Sanofi; GlaxoSmithKline; Genentech; Hospira; Atlantic Healthcare; ActoGeniX; Boehringer Ingelheim; Amgen; Allergan; Seres Therapeutics; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Vedolizumab; Medicine; Crohn's disease; Crohn disease; Endoscopy; Surgery; Disease; Internal medicine","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005174848,0.0001968647,0.0002047446,0.00006266672,0.00003458636,0.000008483213,0.000121722,0.00007841727,0.00002738133],"category_scores_gemma":[0.0000183533,0.0001511008,0.00002679262,0.00002697405,0.0001621699,0.000008152655,0.00008554768,0.0001143064,0.00000754512],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004077594,"about_ca_system_score_gemma":0.00005169765,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000007804219,"about_ca_topic_score_gemma":0.0001265803,"domain_scores_codex":[0.9987639,0.0001366969,0.0001492143,0.0004709715,0.00008293875,0.0003962822],"domain_scores_gemma":[0.9994143,0.000007004299,0.00009270605,0.0002954624,0.00004707605,0.0001434131],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01392123,0.0001032531,0.9851061,0.00002568664,0.0000384576,0.0001542219,0.00002690712,0.0001576491,0.0002459335,0.00001650634,0.00003456982,0.0001695596],"study_design_scores_gemma":[0.005174994,0.001461008,0.9930071,0.00001694233,0.00001882882,0.000007983848,0.00002459661,0.00001725808,0.00004194188,0.00001124522,0.0001230813,0.00009498769],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9991069,0.00005199177,0.00009252233,0.00007443574,0.00007065679,0.000482747,0.00003136075,0.00001256488,0.00007675845],"genre_scores_gemma":[0.998872,0.00001451469,0.0002538764,0.000583428,0.00002967546,0.00005158111,0.00013668,0.00001930988,0.00003895726],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.008746234,"threshold_uncertainty_score":0.6161713,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.002883163305944709,"score_gpt":0.1841886992867892,"score_spread":0.1813055359808445,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}